Alexander Grote

Dr. Alexander Grote

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2024 in Neurology
Verified
Journal Article
Open access
MSMaurits W. Sanders
Maurits W. Sanders
IWIskander Van der Wolf
Iskander Van der Wolf
FJFloor E. Jansen
Floor E. Jansen
EAEleonora Aronica
Eleonora Aronica
CHChristoph Helmstaedter
Christoph Helmstaedter
A(as the European Epilepsy Brain Bank Consortium (EEBB)
as the European Epilepsy Brain Bank Consortium (EEBB)
Patients with presumed nonlesional focal epilepsy-based on either MRI or histopathologic findings-have a lower success rate of epilepsy surgery compared with lesional patients. In this study, we aimed to characterize a large group of patients with focal epilepsy who underwent epilepsy surgery despite a normal MRI and had no lesion on histopathology. Determinants of their postoperative seizure outcomes were further studied. We designed an observational multicenter cohort study of MRI-negative and histopathology-negative patients who were derived from the European Epilepsy Brain Bank and underwent epilepsy surgery between 2000 and 2012 in 34 epilepsy surgery centers within Europe. We collected data on clinical characteristics, presurgical assessment, including genetic testing, surgery characteristics, postoperative outcome, and treatment regimen. Of the 217 included patients, 40% were seizure-free (Engel I) 2 years after surgery and one-third of patients remained seizure-free after 5 years. Temporal lobe surgery (adjusted odds ratio [AOR]: 2.62; 95% CI 1.19-5.76), shorter epilepsy duration (AOR for duration: 0.94; 95% CI 0.89-0.99), and completely normal histopathologic findings-versus nonspecific reactive gliosis-(AOR: 4.69; 95% CI 1.79-11.27) were significantly associated with favorable seizure outcome at 2 years after surgery. Of patients who underwent invasive monitoring, only 35% reached seizure freedom at 2 years. Patients with parietal lobe resections had lowest seizure freedom rates (12.5%). Among temporal lobe surgery patients, there was a trend toward favorable outcome if hippocampectomy was part of the resection strategy (OR: 2.94; 95% CI 0.98-8.80). Genetic testing was only sporadically performed. This study shows that seizure freedom can be reached in 40% of nonlesional patients with both normal MRI and histopathology findings. In particular, nonlesional temporal lobe epilepsy should be regarded as a relatively favorable group, with almost half of patients achieving seizure freedom at 2 years after surgery-even more if the hippocampus is resected-compared with only 1 in 5 nonlesional patients who underwent extratemporal surgery. Patients with an electroclinically identified focus, who are nonlesional, will be a promising group for advanced molecular-genetic analysis of brain tissue specimens to identify new brain somatic epilepsy genes or epilepsy-associated molecular pathways.

1 December 2011 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
PDF file
KPKatharina Pernhorst
Katharina Pernhorst
ARAnna Raabe
Anna Raabe
PNPitt Niehusmann
Pitt Niehusmann
KLKaren M.J. van Loo
Karen M.J. van Loo
AGAlexander Grote
Alexander Grote
ABAlbert J. Becker
Albert J. Becker
The functional consequences of single nucleotide polymorphisms associated with episodic brain disorders such as epilepsy and depression are unclear. Allelic associations with generalized epilepsies have been reported for single nucleotide polymorphisms rs1883415 ( ALDH5A1 ; succinic semialdehyde dehydrogenase) and rs4906902 ( GABRB3 ; GABAA β3), both of which are present in the 5′ regulatory region of genes involved in γ-aminobutyric acid (GABA) homeostasis. To addresstheir allelic association with episodic brain disorders and allele-specific impact on the transcriptional regulation of these genes in human brain tissue, DNA and messenger RNA (mRNA) isolated from hippocampi were obtained at epilepsy surgery of 146 pharmacoresistant mesial temporal lobe epilepsy (mTLE) patients and from 651 healthy controls. We found that the C allele of rs1883415 is accumulated to a greater extentin mTLE versus controls. By real-time quantitative reverse transcription–polymerase chain reaction analyses, individuals homozygous for the C allele showed higher ALDH5A1 mRNA expression. The rs4906902 G allele of the GABRB3 gene was overrepresented in mTLE patients with depression; individuals homozygous for the G allele showed reduced GABRB3 mRNA expression. Bioinformatic analyses suggest that rs1883415 and rs4906902 alter the DNA binding affinity of the transcription factors Egr-3 in ALDH5A1 and MEF-2 in GABRB3 promoters, respectively. Using in vitro luciferase transfection assays, we observed that, in both cases, the transcription factorsregulate gene expression depending on the allelic variant in the same direction as in the human hippocampi. Our data suggest that distinct promoter variants may sensitize individuals for differential, potentially stimulus-induced alterations of GABA homeostasis-relevant gene expression. This might contribute to the episodic onset of symptoms and point to new targets for pharmacotherapies.

18 February 2020 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
JSJürgen Serth
Jürgen Serth
IPInga Peters
Inga Peters
NDNatalia Dubrowinskaja
Natalia Dubrowinskaja
CRChristel Reese
Christel Reese
KAKnut Albrecht
Knut Albrecht
MKMarkus A. Kuczyk
Markus A. Kuczyk
Background: While a considerable number of tumor-specific hypermethylated loci have been identified in renal cell cancer (RCC), DNA methylation of loci showing successive increases in normal, tumoral, and metastatic tissues could point to genes with high relevance both for the process of tumor development and progression. Here, we report that DNA methylation of a locus in a genomic region corresponding to the 3′UTR of the transcription factor T-box brain 1 (TBR1) mRNA accumulates in normal renal tissues with age and possibly increased body mass index. Moreover, a further tissue-specific increase of methylation was observed for tumor and metastatic tissue samples. Results: Biometric analyses of the TCGA KIRC methylation data revealed candidate loci for age-dependent and tumor-specific DNA methylation within the last exon and in a genomic region corresponding to the 3′UTR TBR1 mRNA. To evaluate whether methylation of TBR1 shows association with RCC carcinogenesis, we measured 15 tumor cell lines and 907 renal tissue samples including 355 normal tissues, 175 tissue pairs of normal tumor adjacent and corresponding tumor tissue as well 202 metastatic tissues samples of lung, bone, and brain metastases by the use of pyrosequencing. Statistical evaluation demonstrated age-dependent methylation in normal tissue (R = 0.72, p < 2 × 10−16), association with adiposity (P = 0.019) and tumor-specific hypermethylation (P = 6.1 × 10−19) for RCC tissues. Comparison of tumor and metastatic tissues revealed higher methylation in renal cancer metastases (P = 2.65 × 10−6). Conclusions: Our analyses provide statistical evidence of association between methylation of TBR1 and RCC development and disease progression.

1 February 2016 in Neurobiology of Disease
Verified
Journal Article
Closed access
AGAlexander Grote
Alexander Grote
BRBarbara K. Robens
Barbara K. Robens
IBIngmar Blümcke
Ingmar Blümcke
ABAlbert J. Becker
Albert J. Becker
SSSusanne Schoch
Susanne Schoch
EGEva Gembé
Eva Gembé

23 May 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Miriam H. A. BoppMiriam H. A. Bopp
Miriam H. A. Bopp
AGAlexander Grote
Alexander Grote
MGMarko Gjorgjevski
Marko Gjorgjevski
Mirza PojskicMirza Pojskic
Mirza Pojskic
BSBenjamin Saß
Benjamin Saß
Christopher NimskyChristopher Nimsky
Christopher Nimsky
Despite its broad use in cranial and spinal surgery, navigation support and microscope-based augmented reality (AR) have not yet found their way into posterior fossa surgery in the sitting position. While this position offers surgical benefits, navigation accuracy and thereof the use of navigation itself seems limited. Intraoperative ultrasound (iUS) can be applied at any time during surgery, delivering real-time images that can be used for accuracy verification and navigation updates. Within this study, its applicability in the sitting position was assessed. Data from 15 patients with lesions within the posterior fossa who underwent magnetic resonance imaging (MRI)-based navigation-supported surgery in the sitting position were retrospectively analyzed using the standard reference array and new rigid image-based MRI-iUS co-registration. The navigation accuracy was evaluated based on the spatial overlap of the outlined lesions and the distance between the corresponding landmarks in both data sets, respectively. Image-based co-registration significantly improved (p < 0.001) the spatial overlap of the outlined lesion (0.42 ± 0.30 vs. 0.65 ± 0.23) and significantly reduced (p < 0.001) the distance between the corresponding landmarks (8.69 ± 6.23 mm vs. 3.19 ± 2.73 mm), allowing for the sufficient use of navigation and AR support. Navigated iUS can therefore serve as an easy-to-use tool to enable navigation support for posterior fossa surgery in the sitting position.

1 June 2016 in Life Sciences
Verified
Journal Article
Closed access
BRBarbara K. Robens
Barbara K. Robens
EGEva Gembé
Eva Gembé
JFJana Fassunke
Jana Fassunke
ABAlbert J. Becker
Albert J. Becker
SSSusanne Schoch
Susanne Schoch
AGAlexander Grote
Alexander Grote